The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for ...

The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...

Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

As President Joe Biden is less than two weeks away from leaving office, some conservatives have accused him of trying to ...

Coffee beans contain powerful antioxidants. Here's what the research says about coffee's impact on heart health, brain health, weight loss and mood.

Clinical trials are underway in Colorado for a new drug that could extend a dog’s lifespan. Loyal, a San Francisco-based ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The FDA has failed to meet its mandated targets for domestic and foreign food safety inspections since fiscal 2018, the US ...

Target currently has recalls for five foods sold in states across the country based on FDA recalls of the same products. Target has said: "Our guests, your safety, is our highest priority. For this ...

Merit Medical Systems' stock is up 40% from last spring's lows, driven by strong Q3 results and positive analyst sentiment.

The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...